Precision Vaccine Adjuvants for Older Adults: A Scoping Review( )

Older adults, defined as those ≥60 years of age, are a growing population vulnerable to infections including severe acute respiratory syndrome coronavirus 2. Although immunization is a key to protecting this population, immunosenescence can impair responses to vaccines. Adjuvants can increase the im...

Descripción completa

Detalles Bibliográficos
Autores principales: Nanishi, Etsuro, Angelidou, Asimenia, Rotman, Chloe, Dowling, David J, Levy, Ofer, Ozonoff, Al
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Precision Vaccines Supplement
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9376277/
https://www.ncbi.nlm.nih.gov/pubmed/35439286
http://dx.doi.org/10.1093/cid/ciac302

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9376277/
https://www.ncbi.nlm.nih.gov/pubmed/35439286
http://dx.doi.org/10.1093/cid/ciac302

Ejemplares similares